Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912236 · ClinicalTrials.gov registry record
Evaluation of High-Density Lipoprotein in Obesity Study
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 77
- Enrollment target
NCT00912236 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 77 participants.
The verdict
NCT00912236 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
Obesity is associated with an impaired functioning HDL (good cholesterol) resulting in an acceleration in the development of atherosclerosis. This study will evaluate HDL functionality in patients with BMI (Body Mass Index) 20 - 25 and BMI \>30
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00912236
The ClinicalTrials.gov registry entry for NCT00912236 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00912236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00912236 about?
NCT00912236 is a clinical study titled "Evaluation of High-Density Lipoprotein in Obesity Study". Obesity is associated with an impaired functioning HDL (good cholesterol) resulting in an acceleration in the development of atherosclerosis. This study will evaluate HDL functionality in patients with BMI (Body Mass Index) 20 - 25 and BMI \>30
What is the current status of trial NCT00912236?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2009-06. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00912236?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.